Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board287
Editorial Board183
“Fibromyalgia syndrome” related to Essure devices153
Leflunomide: A safe and effective alternative in systemic lupus erythematosus117
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review110
Editorial Board105
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis97
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch90
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome86
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence80
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective79
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management76
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)75
Endometriosis and autoimmunity75
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases74
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis72
Susac syndrome: A scoping review71
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders70
Editorial Board69
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review69
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology 69
Can anticoagulation be withdrawn in APS patients after aPL negativization?66
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy65
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination60
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate60
Seronegative autoimmune diseases: A challenging diagnosis59
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned59
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature58
Autoimmune pre-disease51
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered51
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease50
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases50
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 2449
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes49
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy49
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.48
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 202146
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases44
Autoimmunity in vitiligo: Therapeutic implications and opportunities43
Psychiatric manifestations of autoimmune encephalitis42
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis42
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction42
Cardiovascular outcome in adult-onset Kawasaki disease42
0.10271310806274